Drugmaker Indivior seeks shareholder approval to move primary listing from London to New York April 25, 2024 Opioid dependence treatment maker Indivior has confirmed a plan to move its primary stock market listing from London to New York this summer in yet another blow to the capital's beleaguered bourse.
Hikma: Pharma giant starts year strong as new product sales surge in key markets April 25, 2024 In 2023, the group became the second-largest pharmaceutical company in Middle East and North Africa by sales.
WPP expects to return to growth in second-half as AI tools ‘deployed at scale’ April 25, 2024 For the full year, the company said it expected to report like-for-like revenue growth less pass-through costs of zero to one per cent.
Barclays shares hit two-year high after profit beats estimates, but investment bank struggles April 25, 2024 Barclays has reported an 11 per cent drop in profit - slightly outperforming analysts' estimates - as the boost from higher interest rates fades and its investment bank struggles to compete with its Wall Street rivals.
Astrazeneca’s revenue surges as pipeline investments pay off April 25, 2024 Pascal Soriot, chief executive officer of AstraZeneca, said: "Astrazeneca had a very strong start in 2024 with substantial total revenue growth of 19 per cent in the first quarter.
Abrdn records rebound in flows as boss says cost-cutting is ‘on track’ April 24, 2024 Money manager Abrdn said its cost-cutting programme was “on track” today as its total funds under management ticked up in the first three months of the year ann the flow of cash into the firm rebounded.
Warpaint London expands into Superdrug and Boots as revenue leaps 40 per cent April 24, 2024 Warpaint cosmetics has reported a 40 per cent rise in revenue for the year ended 31st December, helped by the launch of its products in New Look and Superdrug stores.
Reckitt Benckiser: Nutrition arm bruised amid baby formula litigation case April 24, 2024 Like-for-like sales at its nutrition arm fell by 9.9 per cent to £591m, which more than offset growth of 7.1 per cent at its hygiene arm and one per cent at its health arm.
Proxy battle fails to erupt as investors wave through FTSE 350 payouts April 24, 2024 The battle over paypackets for London’s top bosses failed to materialise in the opening months of the year as investors snubbed proxy firms and waved through bigger salaries for executives, new data suggests.
FTSE 100 closes at new record after breaching all-time high April 23, 2024 "This positive showing is exactly what’s needed to help repair the reputation of the UK stock market," Russ Mould, investment director at AJ Bell said.